Predictors of Death in Contemporary Adult Patients with Eisenmenger Syndrome : a Multicentre Study

Autor: A. S. Jensen, Lars Søndergaard, Wei Li, Gerhard-Paul Diller, Cristel S. Hjortshøj, Michael J. Landzberg, Alexander R. Opotowsky, Ilja M. Blok, Hong Gu, Stephen J. Wort, Katja Prokšelj, Michael A. Gatzoulis, Ulf Thilén, Konstantinos Dimopoulos, Kamil Szostek, Michele D'Alto, Giancarlo Scognamiglio, Werner Budts, Aleksander Kempny, Mette-Elise Estensen, Lidia Tomkiewicz-Pająk, Barbara J. Mulder
Přispěvatelé: Cardiology, APH - Personalized Medicine, APH - Aging & Later Life, ACS - Heart failure & arrhythmias
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
Pediatrics
Cardiac & Cardiovascular Systems
Heart malformation
030204 cardiovascular system & hematology
GUIDELINES
THERAPY
Severity of Illness Index
Electrocardiography
0302 clinical medicine
Risk Factors
pulmonary hypertension
Medicine
030212 general & internal medicine
Young adult
1102 Cardiorespiratory Medicine and Haematology
Aged
80 and over

SURVIVAL PROSPECTS
DEFECTS
Middle Aged
Prognosis
CONGENITAL HEART-DISEASE
PROGNOSTIC VALUE
Phenotype
Echocardiography
Female
Cardiology and Cardiovascular Medicine
Risk assessment
Life Sciences & Biomedicine
Adult
PULMONARY ARTERIAL-HYPERTENSION
medicine.medical_specialty
Adolescent
INTERNATIONAL SOCIETY
Walk Test
Risk Assessment
1117 Public Health and Health Services
03 medical and health sciences
Young Adult
Oxygen Consumption
Physiology (medical)
Severity of illness
MANAGEMENT
Humans
Intensive care medicine
Aged
Proportional Hazards Models
Science & Technology
business.industry
Proportional hazards model
1103 Clinical Sciences
Eisenmenger Complex
medicine.disease
mortality
Pulmonary hypertension
Peripheral Vascular Disease
Cardiovascular System & Hematology
REGISTRY
Eisenmenger syndrome
Cardiovascular System & Cardiology
business
Biomarkers
Follow-Up Studies
Zdroj: Circulation, 135(15), 1432-1440. Lippincott Williams and Wilkins
ISSN: 0009-7322
Popis: Background: Eisenmenger syndrome is associated with substantial morbidity and mortality. There is no consensus, however, on mortality risk stratification. We aimed to investigate survival and predictors of death in a large, contemporary cohort of Eisenmenger syndrome patients. Methods: In a multicenter approach, we identified adults with Eisenmenger syndrome under follow-up between 2000 and 2015. We examined survival and its association with clinical, electrocardiographic, echocardiographic, and laboratory parameters. Results: We studied 1098 patients (median age, 34.4 years; range, 16.1–84.4 years; 65.1% female; 31.9% with Down syndrome). The majority had a posttricuspid defect (n=643, 58.6%), followed by patients with a complex (n=315, 28.7%) and pretricuspid lesion (n=140, 12.7%). Over a median follow-up of 3.1 years (interquartile range, 1.4–5.9), allowing for 4361.6 patient-years observation, 278 patients died and 6 underwent transplantation. Twelve parameters emerged as significant predictors of death on univariable analysis. On multivariable Cox regression analysis, only age (hazard ratio [HR], 1.41/10 years; 95% confidence interval [CI], 1.24–1.59; P P =0.041), oxygen saturation at rest (HR, 0.53/10%; 95% CI, 0.43–0.65; P P =0.013), and presence of pericardial effusion (HR, 2.41; 95% CI, 1.59–3.66; P Conclusions: There is significant premature mortality among contemporary adults with Eisenmenger syndrome. We report, herewith, a multivariable mortality risk stratification model based on 5 simple, noninvasive predictors of death in this population.
Databáze: OpenAIRE